Siemens Healthineers AG (SHL)

Basic

  • Market Cap

    €59.07B

  • EV

    €74.13B

  • Shares Out

    1,115.79M

  • Revenue

    €21.68B

  • Employees

    71,000

Margins

  • Gross

    35.56%

  • EBITDA

    14.81%

  • Operating

    9.84%

  • Pre-Tax

    8.89%

  • Net

    6.96%

  • FCF

    5.91%

Returns (5Yr Avg)

  • ROA

    4.76%

  • ROE

    12.21%

  • ROCE

    10.33%

  • ROIC

    6.41%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    €56.64

  • P/E

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

Per Share

  • Rev

    €19.37

  • Earnings (Dil)

    €1.34

  • FCF

    €1.14

  • Book Value

    €16.2

Growth (CAGR)

  • Rev 3Yr

    14.45%

  • Rev 5Yr

    10.05%

  • Rev 10Yr

    —

  • Dil EPS 3Yr

    -1.45%

  • Dil EPS 5Yr

    1.24%

  • Dil EPS 10Yr

    —

  • Rev Fwd 2Yr

    5.9%

  • EBITDA Fwd 2Yr

    20.26%

  • EPS Fwd 2Yr

    15.15%

  • EPS LT Growth Est

    11.22%

Dividends

  • Yield

    —

  • Payout

    70.48%

  • DPS

    €0.95

  • DPS Growth 3Yr

    5.9%

  • DPS Growth 5Yr

    6.3%

  • DPS Growth 10Yr

    —

  • DPS Growth Fwd 2Yr

    13.55%

Select a metric from the list below to chart it

Sep '15
Sep '16
Sep '17
Sep '18
Sep '19
Sep '20
Sep '21
Sep '22
Sep '23
Metric
Sep '15
Sep '16
Sep '17
Sep '18
Sep '19
Sep '20
Sep '21
Sep '22
Sep '23

Total Revenues

14,518.0

14,460.0

17,997.0

21,714.0

21,680.0

Total Revenues % Chg.

8.1%

-0.4%

24.5%

20.7%

-0.2%

Cost of Goods Sold, Total

8,722.0

8,880.0

11,045.0

13,577.0

13,971.0

Gross Profit

5,796.0

5,580.0

6,952.0

8,137.0

7,709.0

Selling General & Admin Expenses, Total

2,214.0

2,279.0

2,817.0

3,408.0

3,607.0

R&D Expenses

1,328.0

1,342.0

1,546.0

1,785.0

1,866.0

Other Operating Expenses

-42.0

15.0

21.0

20.0

103.0

Other Operating Expenses, Total

3,500.0

3,636.0

4,384.0

5,213.0

5,576.0

Operating Income

2,296.0

1,944.0

2,568.0

2,924.0

2,133.0

Interest Expense, Total

-123.0

-76.0

-83.0

-118.0

-296.0

Interest And Investment Income

38.0

53.0

33.0

48.0

85.0

Net Interest Expenses

-85.0

-23.0

-50.0

-70.0

-211.0

Income (Loss) On Equity Invest.

3.0

3.0

5.0

2.0

3.0

Currency Exchange Gains (Loss)

-72.0

211.0

-273.0

-2,022.0

—

Other Non Operating Income (Expenses)

50.0

-214.0

153.0

1,967.0

3.0

EBT, Excl. Unusual Items

2,192.0

1,921.0

2,403.0

2,801.0

1,928.0

Gain (Loss) On Sale Of Assets

—

—

—

—

—

Other Unusual Items

—

34.0

—

—

—

EBT, Incl. Unusual Items

2,192.0

1,955.0

2,403.0

2,801.0

1,928.0

Income Tax Expense

607.0

532.0

658.0

746.0

403.0

Earnings From Continuing Operations

1,585.0

1,423.0

1,745.0

2,055.0

1,525.0

Minority Interest

-18.0

-12.0

-18.0

-17.0

-16.0

Net Income

1,567.0

1,411.0

1,727.0

2,038.0

1,509.0

Net Income to Common Incl Extra Items

1,567.0

1,411.0

1,727.0

2,038.0

1,509.0

Net Income to Common Excl. Extra Items

1,567.0

1,411.0

1,727.0

2,038.0

1,509.0

Total Shares Outstanding

999.3

1,074.1

1,122.7

1,119.4

1,115.8

Weighted Avg. Shares Outstanding

999.2

1,001.9

1,099.7

1,122.8

1,119.5

Weighted Avg. Shares Outstanding Dil

1,000.1

1,004.1

1,103.6

1,127.7

1,123.6

EPS

1.6

1.4

1.6

1.8

1.3

EPS Diluted

1.6

1.4

1.6

1.8

1.3

EBITDA

2,805.0

2,502.0

3,307.0

3,941.0

3,211.0